|
10205
|
KIRIM-KONGO-VAX
|
Crimean-Congo haemorrhagic fever
|
Hemorrhagic
|
Nairovirus
|
negative-sense, single-stranded RNA
|
NA
|
Phase 1
|
The Scientific and Technological Research Council of Turkey
|
2017
|
Turkey
|
18 - 55 years
|
NA
|
Subcutaneous, Intramuscular
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NA
|
NCT03020771
|
https://clinicaltrials.gov/ct2/show/NCT03020771?cond=Crimean-Congo+hemorrhagic+fever&draw=2&rank=1
|
https://ichgcp.net/clinical-trials-registry/NCT03020771
|
|
10379
|
Bulgarian vaccine
|
Crimean-Congo haemorrhagic fever
|
Hemorrhagic
|
Nairovirus
|
negative-sense, single-stranded RNA
|
Inactivated
|
Preclinical
|
NA
|
1974
|
Union of Soviet Socialist Republics
|
16 years and above
|
NA
|
Subcutaneous
|
Aluminum (aluminium hydroxide)
|
NA
|
Prepared from brain tissue of CCHFV infected newborn mice
|
NA
|
NA
|
NA
|
Zabdeno, Mvabea
|
32461819
|
NA
|
https://www.liebertpub.com/doi/10.1089/biores.2019.0057
|
https://www.ema.europa.eu/en/documents/product-information/zabdeno-epar-product-information_en.pdf
|